195 related articles for article (PubMed ID: 33980253)
1. Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations.
Simon M; Mughal SS; Horak P; Uhrig S; Buchloh J; Aybey B; Stenzinger A; Glimm H; Fröhling S; Brors B; Imbusch CD
J Transl Med; 2021 May; 19(1):204. PubMed ID: 33980253
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
[TBL] [Abstract][Full Text] [Related]
3. The proteomic landscape of soft tissue sarcomas.
Burns J; Wilding CP; Krasny L; Zhu X; Chadha M; Tam YB; Ps H; Mahalingam AH; Lee ATJ; Arthur A; Guljar N; Perkins E; Pankova V; Jenks A; Djabatey V; Szecsei C; McCarthy F; Ragulan C; Milighetti M; Roumeliotis TI; Crosier S; Finetti M; Choudhary JS; Judson I; Fisher C; Schuster EF; Sadanandam A; Chen TW; Williamson D; Thway K; Jones RL; Cheang MCU; Huang PH
Nat Commun; 2023 Jun; 14(1):3834. PubMed ID: 37386008
[TBL] [Abstract][Full Text] [Related]
4. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
5. Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines.
Salawu A; Fernando M; Hughes D; Reed MW; Woll P; Greaves C; Day C; Alhajimohammed M; Sisley K
Br J Cancer; 2016 Oct; 115(9):1058-1068. PubMed ID: 27560552
[TBL] [Abstract][Full Text] [Related]
6. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
[TBL] [Abstract][Full Text] [Related]
7. A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis.
Bui NQ; Przybyl J; Trabucco SE; Frampton G; Hastie T; van de Rijn M; Ganjoo KN
Clin Sarcoma Res; 2019; 9():12. PubMed ID: 31528332
[TBL] [Abstract][Full Text] [Related]
8. Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma.
Seidel C; Bartel F; Rastetter M; Bluemke K; Wurl P; Taubert H; Dammann R
Int J Cancer; 2005 Apr; 114(3):442-7. PubMed ID: 15551306
[TBL] [Abstract][Full Text] [Related]
9. New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics.
Gibault L; Pérot G; Chibon F; Bonnin S; Lagarde P; Terrier P; Coindre JM; Aurias A
J Pathol; 2011 Jan; 223(1):64-71. PubMed ID: 21125665
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics analysis of copy number variations of RNA regulatory genes in soft tissue sarcoma.
Wang X; Han Y; Li J; Hong D; Xue Z; Huang H; Du Z; Hou Y; Li H; Li H; Liao H; Xie X; Ding C
Life Sci; 2021 Jan; 265():118734. PubMed ID: 33166590
[TBL] [Abstract][Full Text] [Related]
11. Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry.
Milighetti M; Krasny L; Lee ATJ; Morani G; Szecsei C; Chen Y; Guljar N; McCarthy F; Wilding CP; Arthur A; Fisher C; Judson I; Thway K; Cheang MCU; Jones RL; Huang PH
J Proteomics; 2021 Jun; 241():104236. PubMed ID: 33895336
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
[TBL] [Abstract][Full Text] [Related]
13. Recent progress in the genomics of soft tissue sarcomas.
Conley AP; Trent J; Zhang W
Curr Opin Oncol; 2008 Jul; 20(4):395-9. PubMed ID: 18525334
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.
;
Cell; 2017 Nov; 171(4):950-965.e28. PubMed ID: 29100075
[TBL] [Abstract][Full Text] [Related]
15. Oncopig Soft-Tissue Sarcomas Recapitulate Key Transcriptional Features of Human Sarcomas.
Schachtschneider KM; Liu Y; Mäkeläinen S; Madsen O; Rund LA; Groenen MAM; Schook LB
Sci Rep; 2017 Jun; 7(1):2624. PubMed ID: 28572589
[TBL] [Abstract][Full Text] [Related]
16. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions.
Das S; Idate R; Lana SE; Regan DP; Duval DL
Sci Rep; 2023 Jun; 13(1):10422. PubMed ID: 37369741
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ analysis of soft tissue tumor associated genetic alterations in formalin-fixed paraffin-embedded tissue.
Horn H; Allmanritter J; Doglioni C; Marx A; Müller J; Gattenlöhner S; Staiger AM; Rosenwald A; Ott G; Ott MM
Pathol Res Pract; 2014 Dec; 210(12):804-11. PubMed ID: 25446247
[TBL] [Abstract][Full Text] [Related]
19. Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients.
Starzer AM; Berghoff AS; Hamacher R; Tomasich E; Feldmann K; Hatziioannou T; Traint S; Lamm W; Noebauer-Huhmann IM; Furtner J; Müllauer L; Amann G; Bauer S; Schildhaus HU; Preusser M; Heller G; Brodowicz T
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762319
[TBL] [Abstract][Full Text] [Related]
20.
Seligson ND; Kautto EA; Passen EN; Stets C; Toland AE; Millis SZ; Meyer CF; Hays JL; Chen JL
Oncologist; 2019 Jul; 24(7):973-979. PubMed ID: 30541756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
